رجوع
نطاق اليوم
KWD 100.01
KWD 105.78
نطاق 52 أسبوعًا
KWD 7.58
KWD 120.32
حجم التداول
593,839
متوسط 50 يوم / 200 يوم
KWD 109.41
/
KWD 69.66
الإغلاق السابق
KWD 106.75
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -42.2 | 0.3 |
| P/B | 40.8 | 2.9 |
| ROE % | -87.5 | 3.7 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.9 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 108.750
+6.6%
Low: KWD 77.000
High: KWD 126.000
ربحية السهم المستقبلية
-KWD 4.021
الإيرادات المقدّرة
55 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2029 |
KWD 7.323
KWD 2.677 – KWD 12.941
|
1 B | 4 |
| FY2028 |
KWD 3.638
KWD 2.260 – KWD 5.290
|
700 M | 6 |
| FY2027 |
-KWD 0.297
-KWD 3.180 – KWD 4.650
|
360 M | 9 |
النقاط الرئيسية
Negative free cash flow of -83.72M
النمو
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-87.54%
ROIC-39.78%
Net MarginN/A
Op. MarginN/A
الأمان
Debt / Equity
0.85
Current Ratio7.71
Interest Coverage-11.02
التقييم
P/E Ratio
-42.23
P/B Ratio40.82
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -111.78M |
| ROE | -87.54% | ROA | -45.60% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -83.72M |
| ROIC | -39.78% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.85 | Current Ratio | 7.71 |
| Interest Coverage | -11.02 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -42.23 | P/B Ratio | 40.82 |
| P/S Ratio | N/A | PEG Ratio | -0.89 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 4.72B | Enterprise Value | 4.80B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -111.78M | -63.78M | -40.37M | -29.61M | -9.47M |
| EPS (Diluted) | -2.83 | -2.69 | -2.68 | -2.28 | -0.89 |
| Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -113.27M | -66.23M | -39.39M | -28.36M | -9.56M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 245.12M | 191.22M | 175.70M | 85.91M | 12.96M |
| Total Liabilities | 129.50M | 51.45M | 41.93M | 17.20M | 1.25M |
| Shareholders' Equity | 115.62M | 139.77M | 133.77M | 68.71M | 11.70M |
| Total Debt | 97.95M | 37.45M | 35.24M | 14.89M | 262,488.0 |
| Cash & Equivalents | 22.51M | 30.66M | 24.57M | 84.29M | 11.64M |
| Current Assets | 244.57M | 190.59M | 175.16M | 85.35M | 12.17M |
| Current Liabilities | 31.72M | 14.19M | 6.88M | 2.51M | 1.19M |